7-hydroxy-2-n,n-dipropylaminotetralin has been researched along with Ocular Hypertension in 1 studies
7-hydroxy-2-N,N-dipropylaminotetralin: RN given refers to cpd without isomeric designation
Ocular Hypertension: A condition in which the intraocular pressure is elevated above normal and which may lead to glaucoma.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pretreatment with raclopride, a dopamine D2/D3 receptor antagonist, reduced the ocular hypotensive effect induced by 7-OH-DPAT in vehicle containing CAP thereby supporting the role for dopamine D2/D3 receptors in modulating IOP." | 1.31 | Biodegradable calcium phosphate nanoparticles as a new vehicle for delivery of a potential ocular hypotensive agent. ( Chu, TC; He, Q; Potter, DE, 2002) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chu, TC | 1 |
| He, Q | 1 |
| Potter, DE | 1 |
1 other study available for 7-hydroxy-2-n,n-dipropylaminotetralin and Ocular Hypertension
| Article | Year |
|---|---|
Biodegradable calcium phosphate nanoparticles as a new vehicle for delivery of a potential ocular hypotensive agent.
Topics: Animals; Aqueous Humor; Biodegradation, Environmental; Calcium Phosphates; Dopamine Agonists; Dopami | 2002 |